Orthopedic Soft Tissue Repair Market by Procedure and Injury Location: Global Industry Analysis and Forecast to 2025

Report Code : HC0645

Soft tissue damage occurs due to direct or indirect trauma to muscles, joint capsules and ligaments. Direct trauma or macro-trauma refers to an injury due to sudden overload on ligaments or joint capsules. Indirect trauma results from repeated sub-maximal loading leading to clinical symptoms and signs. Whether injury is caused due to direct or indirect trauma, the ultimate result is tissue dysfunction characterized by inflammation, pain, and altered internal tissue stress. Of all the tissues involved, the least elastic tissue is a tendon.

Examination of an injury in soft tissues such as muscles is done through initial palpation with minimal compression or force in case of acute injuries. If pain has not been provoked at the site, then higher loads or firmer compression is used. Some of the examination techniques used to examine soft tissue damage are inspection, palpation, and peripheral nerve tests, deep tendon reflexes, strength and motor control tests, and gait analysis.

Tissue repair refers to the replacement of a destroyed tissue by a living tissue. It essentially comprises of two components viz. regeneration and repair. In regeneration, the damaged tissue is replaced through the proliferation of surrounding specialized cells which are undamaged. In repair, the damaged tissue is replaced by a granulation tissue that matures to form a scar tissue. The repair process generally comprises of the bleeding, inflammation, proliferation, and remodeling phases. The bleeding phase is a relatively shorter phase and occurs following a trauma or injury. The inflammatory phase increases in magnitude for up to 1 to 3 days before resolving gradually over the next few weeks. The proliferation phase involves generation of repair material such as the scar material. The remodeling phase is important in context of therapy and rehabilitation. In the final outcome, the damaged tissue is repaired with a scar tissue which enables quality recovery from the injury.

The key driving factors for the global orthopedic soft tissue repair market are the rising incidence of sports injuries, increasing geriatric population and obesity in aging people. Sports injuries are a major cause for muscle damage. Usually sports and related physical activities result in damage of the anterior cruciate ligament (ACL). According to 2016 national health statistics report by the U.S. Department of Health and Human Services, on an average, American people aged five years and above sustained around 8.6 million sports and recreation related injuries every year between 2011 and 2014. Geriatric population is more vulnerable to damage of the orthopedic soft tissues as aging may result into changes in skeletal system leading to weak ligaments, arthritis, and ACL tear. Obesity in aging people can increase the possibility of degenerative bone disorders such as osteoporosis and osteoarthritis. The high cost of orthopedic soft tissue repair surgeries and availability of non-surgical alternatives such as PRP (Platelet Rich Plasma) injection can decrease the demand for surgical orthopedic soft tissue repair procedures in the coming years.

With high healthcare expenditure in developed countries, advanced orthopedic soft tissue repair procedures are being designed and developed to facilitate enhanced repair and replacement of damaged tissues. With a rising acceptance of sports on a professional level in developing countries, incidence of sports injuries will prevail over the next few years. Also, due to the presence of high unmet medical needs in emerging nations, acceptance of advanced and affordable orthopedic soft tissue repair procedures will witness a rise in coming years. Increased life expectancy due to advancements in healthcare will ensure prevalence of geriatric population across the globe, which will further contribute to the growth of global orthopedic soft tissue repair market.

Some of the key players in this market are Stryker Corporation, Arthrex, Inc., DePuy Synthes, Inc., Zimmer Biomet, CONMED Corporation, ArthroCare Corporation, and Smith & Nephew plc. These companies focus on strategic acquisitions and mergers in order to gain competitive advantage. For instance, in July 2015, Integra Lifesciences acquired TEI Biosciences Inc. and TEI Medical Inc. to broaden Integra’s portfolio for regenerative wound care and tissue repair. This acquisition offers a regenerative technology platform to the surgeons for indications in wound repair and soft tissue reconstruction.

Orthopedic Soft Tissue Repair Market Segmentation:

By Procedure:

  • Rotator Cuff Repair
  • Pelvic Organ Prolapsed
  • Epicondylitis
  • Cruciate Ligaments Repair
  • Gluteal Tendon Repair
  • Hip Arthroscopy
  • Achilles Tendinosis Repair
  • Biceps Tenodesis
  • Others

By Injury Location:

  • Knee
  • Hip
  • Shoulder
  • Small Joints
  • Others

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers


Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Further Assistance